Document is current

Article History

Received: 27 August 2023

Accepted: 11 September 2024

First Online: 27 September 2024

Declarations

:

: The authors follow the Declaration of Helsinki to protect the patients. Before enrollment of the first patient, this study was approved by the Institutional Review Boards of Asan Medical Center. Written informed consent will be obtained from each participant prior to enrollment. All patients will understand and agree to the aims and processes of the trial, possible results, and risks. An informed consent must be written in the language understood by the patients and explained by an investigator. If patients cannot read an informed consent, an investigator must read it in the presence of a witness. Even if a patient has voluntarily signed an informed consent document, the investigators must discontinue any process at the refusal of the patient at any time. The patient must be supplied with a copy of their signed informed consent document. An original copy will be retained by an investigator for safekeeping.

: Not applicable.

: The authors declare no competing interests.